2.2 – Medical technologies

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767162.

Pillar 2: Innovative industry for citizens

Session 2.2 – Medical technologies

30 October 2018, 14:30-15:30, room STRAUSS 2


The medical technology industry and the nanomedicine field are important economic and social players in Europe. The session will provide insights and examples about how to overcome current challenges, demonstrating medical devices in relevant industrial environments and facilitating the development of new and safe medical technologies. A specific interest will be on the impact of the new EU regulatory frame for medical devices. Attention will also be paid to aspects related to how Test Beds should make design, development, testing, safety assessment and upscaling of new/existing medical device services available to industry in compliance with EU regulatory frameworks, as well as how technologies can help to increase the quality and speed of medical treatments without increasing costs for society.


Please find below the speakers, who will contribute to this session (The speakers’ order might not correspond to the order within the sessions!):

Moderator: Klaus-Michael Weltring, Nanobioanalytic Muenster, ETP Nanomedicine

Rapporteur: Wim Cuypers

Patrick Boisseau

VP Healthtech
CEATech

Anneliese Pönninger

Business Development Manager
EV Group

Oskar Hoffmann

University of Vienna

Klaus-Michael Weltring

Managing Director
Bioanalytik Münster e. V.